logo

MESO

Mesoblast·NASDAQ
--
--(--)
--
--(--)

MESO fundamentals

Mesoblast (MESO) released its earnings on Feb 27, 2026: revenue was 51.34M (YoY --), missed estimates; EPS was -0.311 (YoY --), missed estimates.
Revenue / YoY
51.34M
--
EPS / YoY
-0.311
--
Report date
Feb 27, 2026
MESO Earnings Call Summary for Q2,2026
  • Ryoncil Growth: FY 2026 revenue guidance of $110-120 million, with 49 centers onboarded and 20% market share target by year-end.
  • Financial Strength: $130 million cash on hand and $125 million credit facility to support growth.
  • Pipeline Momentum: Rexlemestrocel-L Phase III enrollment complete; Revascor BLA filing for full approval in Q2 2026.
  • Strategic Expansion: Adult GVHD trial underway, targeting a 3x larger market than pediatric GVHD.
EPS
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q2,undefined
Q3,undefined
Q4,undefined
Q2,2025
Q3,undefined
Q4,2025
Q2,2026
Actual
-0.2693-0.5689-0.3992-0.4153-0.4162-0.3034-0.3309-0.3793-0.311-0.3224-0.2304-0.3148-0.2399-0.2655-0.311
Forecast
-0.3451-0.3337-0.0664-0.2402-0.0759-0.1849-0.365-0.3856-0.256-0.1944-0.3097-0.2655-0.3148-0.2769-0.237
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+21.96%
-70.48%
-501.20%
-72.90%
-448.35%
-64.09%
+9.34%
+1.63%
-21.48%
-65.84%
+25.61%
-18.57%
+23.79%
+4.12%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-31.22%
Revenue
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q2,undefined
Q3,undefined
Q4,undefined
Q2,2025
Q3,undefined
Q4,2025
Q2,2026
Actual
--------------12.20M701.00K1.30M2.24M1.92M2.00M2.40M2.38M2.01M2.21M1.50M2.13M1.94M1.90M------------51.34M
Forecast
--------------9.05M12.71M40.58M15.63M29.20M17.71M2.35M3.50M2.10M7.59M3.47M2.10M2.14M2.38M------------53.06M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+34.80%
-94.48%
-96.78%
-85.66%
-93.44%
-88.72%
+2.32%
-31.91%
-4.24%
-70.86%
-56.64%
+1.62%
-9.38%
-20.28%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-3.25%

Earnings Call